1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Influenza Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Influenza Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Influenza Vaccine by Country/Region, 2017, 2022 & 2028 2.2 Influenza Vaccine Segment by Type 2.2.1 Trivalent Influenza Vaccine 2.2.2 Quadrivalent Influenza Vaccine 2.3 Influenza Vaccine Sales by Type 2.3.1 Global Influenza Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global Influenza Vaccine Sale Price by Type (2017-2022) 2.4 Influenza Vaccine Segment by Application 2.4.1 For Children (6 months to 3 years) 2.4.2 For Adults and Children over 3 years 2.5 Influenza Vaccine Sales by Application 2.5.1 Global Influenza Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global Influenza Vaccine Sale Price by Application (2017-2022) 3 Global Influenza Vaccine by Company 3.1 Global Influenza Vaccine Breakdown Data by Company 3.1.1 Global Influenza Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global Influenza Vaccine Sales Market Share by Company (2020-2022) 3.2 Global Influenza Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global Influenza Vaccine Revenue by Company (2020-2022) 3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global Influenza Vaccine Sale Price by Company 3.4 Key Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution 3.4.2 Players Influenza Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Influenza Vaccine by Geographic Region 4.1 World Historic Influenza Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global Influenza Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Influenza Vaccine Annual Revenue by Geographic Region 4.2 World Historic Influenza Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global Influenza Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global Influenza Vaccine Annual Revenue by Country/Region 4.3 Americas Influenza Vaccine Sales Growth 4.4 APAC Influenza Vaccine Sales Growth 4.5 Europe Influenza Vaccine Sales Growth 4.6 Middle East & Africa Influenza Vaccine Sales Growth 5 Americas 5.1 Americas Influenza Vaccine Sales by Country 5.1.1 Americas Influenza Vaccine Sales by Country (2017-2022) 5.1.2 Americas Influenza Vaccine Revenue by Country (2017-2022) 5.2 Americas Influenza Vaccine Sales by Type 5.3 Americas Influenza Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Influenza Vaccine Sales by Region 6.1.1 APAC Influenza Vaccine Sales by Region (2017-2022) 6.1.2 APAC Influenza Vaccine Revenue by Region (2017-2022) 6.2 APAC Influenza Vaccine Sales by Type 6.3 APAC Influenza Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Influenza Vaccine by Country 7.1.1 Europe Influenza Vaccine Sales by Country (2017-2022) 7.1.2 Europe Influenza Vaccine Revenue by Country (2017-2022) 7.2 Europe Influenza Vaccine Sales by Type 7.3 Europe Influenza Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Influenza Vaccine by Country 8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa Influenza Vaccine Sales by Type 8.3 Middle East & Africa Influenza Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Influenza Vaccine 10.3 Manufacturing Process Analysis of Influenza Vaccine 10.4 Industry Chain Structure of Influenza Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Influenza Vaccine Distributors 11.3 Influenza Vaccine Customer 12 World Forecast Review for Influenza Vaccine by Geographic Region 12.1 Global Influenza Vaccine Market Size Forecast by Region 12.1.1 Global Influenza Vaccine Forecast by Region (2023-2028) 12.1.2 Global Influenza Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Influenza Vaccine Forecast by Type 12.7 Global Influenza Vaccine Forecast by Application 13 Key Players Analysis 13.1 CSL 13.1.1 CSL Company Information 13.1.2 CSL Influenza Vaccine Product Offered 13.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 CSL Main Business Overview 13.1.5 CSL Latest Developments 13.2 GSK 13.2.1 GSK Company Information 13.2.2 GSK Influenza Vaccine Product Offered 13.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 GSK Main Business Overview 13.2.5 GSK Latest Developments 13.3 Sanofi Pasteur 13.3.1 Sanofi Pasteur Company Information 13.3.2 Sanofi Pasteur Influenza Vaccine Product Offered 13.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Sanofi Pasteur Main Business Overview 13.3.5 Sanofi Pasteur Latest Developments 13.4 Mylan 13.4.1 Mylan Company Information 13.4.2 Mylan Influenza Vaccine Product Offered 13.4.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Mylan Main Business Overview 13.4.5 Mylan Latest Developments 13.5 Hulan Bio 13.5.1 Hulan Bio Company Information 13.5.2 Hulan Bio Influenza Vaccine Product Offered 13.5.3 Hulan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Hulan Bio Main Business Overview 13.5.5 Hulan Bio Latest Developments 13.6 AstraZeneca 13.6.1 AstraZeneca Company Information 13.6.2 AstraZeneca Influenza Vaccine Product Offered 13.6.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 AstraZeneca Main Business Overview 13.6.5 AstraZeneca Latest Developments 13.7 CCBIO 13.7.1 CCBIO Company Information 13.7.2 CCBIO Influenza Vaccine Product Offered 13.7.3 CCBIO Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 CCBIO Main Business Overview 13.7.5 CCBIO Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Trivalent Influenza Vaccine Table 4. Major Players of Quadrivalent Influenza Vaccine Table 5. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses) Table 6. Global Influenza Vaccine Sales Market Share by Type (2017-2022) Table 7. Global Influenza Vaccine Revenue by Type (2017-2022) & ($ million) Table 8. Global Influenza Vaccine Revenue Market Share by Type (2017-2022) Table 9. Global Influenza Vaccine Sale Price by Type (2017-2022) & (USD/Doses) Table 10. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses) Table 11. Global Influenza Vaccine Sales Market Share by Application (2017-2022) Table 12. Global Influenza Vaccine Revenue by Application (2017-2022) Table 13. Global Influenza Vaccine Revenue Market Share by Application (2017-2022) Table 14. Global Influenza Vaccine Sale Price by Application (2017-2022) & (USD/Doses) Table 15. Global Influenza Vaccine Sales by Company (2020-2022) & (M Doses) Table 16. Global Influenza Vaccine Sales Market Share by Company (2020-2022) Table 17. Global Influenza Vaccine Revenue by Company (2020-2022) ($ Millions) Table 18. Global Influenza Vaccine Revenue Market Share by Company (2020-2022) Table 19. Global Influenza Vaccine Sale Price by Company (2020-2022) & (USD/Doses) Table 20. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area Table 21. Players Influenza Vaccine Products Offered Table 22. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Influenza Vaccine Sales by Geographic Region (2017-2022) & (M Doses) Table 26. Global Influenza Vaccine Sales Market Share Geographic Region (2017-2022) Table 27. Global Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Influenza Vaccine Sales by Country/Region (2017-2022) & (M Doses) Table 30. Global Influenza Vaccine Sales Market Share by Country/Region (2017-2022) Table 31. Global Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Influenza Vaccine Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Influenza Vaccine Sales by Country (2017-2022) & (M Doses) Table 34. Americas Influenza Vaccine Sales Market Share by Country (2017-2022) Table 35. Americas Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Influenza Vaccine Revenue Market Share by Country (2017-2022) Table 37. Americas Influenza Vaccine Sales by Type (2017-2022) & (M Doses) Table 38. Americas Influenza Vaccine Sales Market Share by Type (2017-2022) Table 39. Americas Influenza Vaccine Sales by Application (2017-2022) & (M Doses) Table 40. Americas Influenza Vaccine Sales Market Share by Application (2017-2022) Table 41. APAC Influenza Vaccine Sales by Region (2017-2022) & (M Doses) Table 42. APAC Influenza Vaccine Sales Market Share by Region (2017-2022) Table 43. APAC Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Influenza Vaccine Revenue Market Share by Region (2017-2022) Table 45. APAC Influenza Vaccine Sales by Type (2017-2022) & (M Doses) Table 46. APAC Influenza Vaccine Sales Market Share by Type (2017-2022) Table 47. APAC Influenza Vaccine Sales by Application (2017-2022) & (M Doses) Table 48. APAC Influenza Vaccine Sales Market Share by Application (2017-2022) Table 49. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses) Table 50. Europe Influenza Vaccine Sales Market Share by Country (2017-2022) Table 51. Europe Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Influenza Vaccine Revenue Market Share by Country (2017-2022) Table 53. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses) Table 54. Europe Influenza Vaccine Sales Market Share by Type (2017-2022) Table 55. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses) Table 56. Europe Influenza Vaccine Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses) Table 58. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses) Table 62. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses) Table 64. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Influenza Vaccine Table 66. Key Market Challenges & Risks of Influenza Vaccine Table 67. Key Industry Trends of Influenza Vaccine Table 68. Influenza Vaccine Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Influenza Vaccine Distributors List Table 71. Influenza Vaccine Customer List Table 72. Global Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses) Table 73. Global Influenza Vaccine Sales Market Forecast by Region Table 74. Global Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses) Table 77. Americas Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses) Table 79. APAC Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses) Table 81. Europe Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses) Table 83. Middle East & Africa Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Influenza Vaccine Sales Forecast by Type (2023-2028) & (M Doses) Table 85. Global Influenza Vaccine Sales Market Share Forecast by Type (2023-2028) Table 86. Global Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Influenza Vaccine Sales Forecast by Application (2023-2028) & (M Doses) Table 89. Global Influenza Vaccine Sales Market Share Forecast by Application (2023-2028) Table 90. Global Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 92. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. CSL Influenza Vaccine Product Offered Table 94. CSL Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 95. CSL Main Business Table 96. CSL Latest Developments Table 97. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. GSK Influenza Vaccine Product Offered Table 99. GSK Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 100. GSK Main Business Table 101. GSK Latest Developments Table 102. Sanofi Pasteur Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. Sanofi Pasteur Influenza Vaccine Product Offered Table 104. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 105. Sanofi Pasteur Main Business Table 106. Sanofi Pasteur Latest Developments Table 107. Mylan Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Mylan Influenza Vaccine Product Offered Table 109. Mylan Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 110. Mylan Main Business Table 111. Mylan Latest Developments Table 112. Hulan Bio Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 113. Hulan Bio Influenza Vaccine Product Offered Table 114. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 115. Hulan Bio Main Business Table 116. Hulan Bio Latest Developments Table 117. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 118. AstraZeneca Influenza Vaccine Product Offered Table 119. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 120. AstraZeneca Main Business Table 121. AstraZeneca Latest Developments Table 122. CCBIO Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 123. CCBIO Influenza Vaccine Product Offered Table 124. CCBIO Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022) Table 125. CCBIO Main Business Table 126. CCBIO Latest Developments List of Figures Figure 1. Picture of Influenza Vaccine Figure 2. Influenza Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Influenza Vaccine Sales Growth Rate 2017-2028 (M Doses) Figure 7. Global Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Trivalent Influenza Vaccine Figure 10. Product Picture of Quadrivalent Influenza Vaccine Figure 11. Global Influenza Vaccine Sales Market Share by Type in 2021 Figure 12. Global Influenza Vaccine Revenue Market Share by Type (2017-2022) Figure 13. Influenza Vaccine Consumed in For Children (6 months to 3 years) Figure 14. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2017-2022) & (M Doses) Figure 15. Influenza Vaccine Consumed in For Adults and Children over 3 years Figure 16. Global Influenza Vaccine Market: For Adults and Children over 3 years (2017-2022) & (M Doses) Figure 17. Global Influenza Vaccine Sales Market Share by Application (2017-2022) Figure 18. Global Influenza Vaccine Revenue Market Share by Application in 2021 Figure 19. Influenza Vaccine Revenue Market by Company in 2021 ($ Million) Figure 20. Global Influenza Vaccine Revenue Market Share by Company in 2021 Figure 21. Global Influenza Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 22. Global Influenza Vaccine Revenue Market Share by Geographic Region in 2021 Figure 23. Global Influenza Vaccine Sales Market Share by Region (2017-2022) Figure 24. Global Influenza Vaccine Revenue Market Share by Country/Region in 2021 Figure 25. Americas Influenza Vaccine Sales 2017-2022 (M Doses) Figure 26. Americas Influenza Vaccine Revenue 2017-2022 ($ Millions) Figure 27. APAC Influenza Vaccine Sales 2017-2022 (M Doses) Figure 28. APAC Influenza Vaccine Revenue 2017-2022 ($ Millions) Figure 29. Europe Influenza Vaccine Sales 2017-2022 (M Doses) Figure 30. Europe Influenza Vaccine Revenue 2017-2022 ($ Millions) Figure 31. Middle East & Africa Influenza Vaccine Sales 2017-2022 (M Doses) Figure 32. Middle East & Africa Influenza Vaccine Revenue 2017-2022 ($ Millions) Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2021 Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2021 Figure 35. United States Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 36. Canada Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 37. Mexico Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 38. Brazil Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 39. APAC Influenza Vaccine Sales Market Share by Region in 2021 Figure 40. APAC Influenza Vaccine Revenue Market Share by Regions in 2021 Figure 41. China Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 42. Japan Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 43. South Korea Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 44. Southeast Asia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 45. India Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 46. Australia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 47. Europe Influenza Vaccine Sales Market Share by Country in 2021 Figure 48. Europe Influenza Vaccine Revenue Market Share by Country in 2021 Figure 49. Germany Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 50. France Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 51. UK Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 52. Italy Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. Russia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2021 Figure 55. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2021 Figure 56. Egypt Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 57. South Africa Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 58. Israel Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 59. Turkey Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. GCC Country Influenza Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2021 Figure 62. Manufacturing Process Analysis of Influenza Vaccine Figure 63. Industry Chain Structure of Influenza Vaccine Figure 64. Channels of Distribution Figure 65. Distributors Profiles